Mindray Medical (MR) Tops Q3 EPS by 7c

Mindray Medical (NYSE: MR) reported Q3 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $342.35 million.

For earnings history and earnings-related data on Mindray Medical (MR) click here.

You May Also Be Interested In

• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
• Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance
• ESSA Bancorp (ESSA) Tops Q2 EPS by 13c